No Benefit of BCR-ABL1 Screening in
Polycythemia
Published: July 1, 2016 | DOI: https://doi.org/10.7860/JCDR/2016/.8176
Stephen E. Langabeer
1. Clinical Scientist, Cancer Molecular Diagnostics, St. James’s Hospital, Dublin, Ireland.
Correspondence Address :
Dr. Stephen E. Langabeer,
Cancer Molecular Diagnostics, Central Pathology Laboratory
St. James’s Hospital, Dublin 8, Ireland.
E-mail: slangabeer@stjames.ie
Keywords
Chronic myeloid leukemia, Erythrocytosis, Molecular diagnostics